Literature DB >> 1392703

Detecting susceptibility to malignant hyperthermia.

F R Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1392703      PMCID： PMC1881639          DOI： 10.1136/bmj.304.6830.791

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Missed neuroleptic malignant syndrome.

Authors:  D S Renwick; A Chandraker; P Bannister
Journal:  BMJ       Date:  1992-03-28

2.  Another death from Ecstacy.

Authors:  N T Campkin; U M Davies
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 5.344

3.  Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.

Authors:  S J Healy; J J Heffron; M Lehane; D G Bradley; K Johnson; T V McCarthy
Journal:  BMJ       Date:  1991-11-16

4.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

5.  The association between the neuroleptic malignant syndrome and malignant hyperthermia.

Authors:  P J Adnet; R M Krivosic-Horber; M M Adamantidis; G Haudecoeur; C A Adnet-Bonte; F Saulnier; B A Dupuis
Journal:  Acta Anaesthesiol Scand       Date:  1989-11       Impact factor: 2.105

6.  A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.

Authors:  E F Gillard; K Otsu; J Fujii; V K Khanna; S de Leon; J Derdemezi; B A Britt; C L Duff; R G Worton; D H MacLennan
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

7.  Evidence for genetic heterogeneity in malignant hyperthermia susceptibility.

Authors:  R C Levitt; N Nouri; A E Jedlicka; V A McKusick; A R Marks; J G Shutack; J E Fletcher; H Rosenberg; D A Meyers
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

8.  Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.

Authors:  J Fujii; K Otsu; F Zorzato; S de Leon; V K Khanna; J E Weiler; P J O'Brien; D H MacLennan
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

9.  Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.

Authors:  T V McCarthy; J M Healy; J J Heffron; M Lehane; T Deufel; F Lehmann-Horn; M Farrall; K Johnson
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

10.  Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.

Authors:  D H MacLennan; C Duff; F Zorzato; J Fujii; M Phillips; R G Korneluk; W Frodis; B A Britt; R G Worton
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962
  10 in total
  1 in total

Review 1.  The genetics of malignant hyperthermia.

Authors:  S P Ball; K J Johnson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.